Scynexis SCYX 深 滬
已收盤 08-14 16:00:00 美东时间
5.18
+0.060
+1.17%
華盛通- 最 高5.35
- 今 開5.17
- 成交量 10.15万股
- 最 低 4.99
- 昨 收 5.12
- 總市值 5143.91万
- 52周最高 10.48
- 市盈率 靜 --
- 換手率 1.02%
- 52周最低 3.53
- 委 比 99.01%
- 總股本 993.03万
- 歷史最高 1200.00
- 量 比 0.97
- 振 幅 7.03%
- 歷史最低 4.52
- 每 手 1
- 風險率 1.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股前瞻 | 存储重回风口！高盛唱多闪迪，海力士董事长警告“存储荒”；苹果携手阿里开发中国市场专属大模型
存储重回风口？高盛唱多后，闪迪盘前涨逾7%！海力士董事长警告“存储荒”；苹果携手阿里开发中国市场专属大模型；今晚20:30！美国7月零售销售数据压轴登场>>
08-14 20:25
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
Guggenheim Maintains Buy on SCYNEXIS, Raises Price Target to $33
Guggenheim analyst Vamil Divan maintains SCYNEXIS (NASDAQ:SCYX) with a Buy and raises the price target from $24 to $33.
08-13 22:14
SCYNEXIS Q2 EPS $0.63 Beats $(0.64) Estimate, Sales $235.000K Beat $80.330K Estimate
SCYNEXIS (NASDAQ:SCYX) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $(0.64) by 198.44 percent. This is a 156.25 percent increase over losses of $(1.12) per share from the same period last year. The company reported quarterly sales of $235.000 thousand w...
08-11 04:45
AutoZone, Zscaler And 3 Stocks To Watch Heading Into Tuesday
U.S. stock futures are up, with investor focus on quarterly earnings from AutoZone, Elbit Systems, SCYNEXIS, Box, and Zscaler after the closing bell.
05-26 14:13
SCYNEXIS Announces 1-For-8 Reverse Stock Split, Effective May 29
SCYNEXIS, Inc. (NASDAQ:SCYX) ("SCYNEXIS"), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare diseases, today announced that it will effect a reverse stock split of its
05-23 04:16
SCYNEXIS Q1 EPS $(0.42) Misses $(0.12) Estimate
SCYNEXIS (NASDAQ:SCYX) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.12) by 281.82 percent. This is a 281.82 percent decrease over losses of $(0.11) per share from the
05-12 04:34
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SCYNEXIS, Inc. announced on May 6, 2026, that its Compensation Committee approved inducement equity awards for a new Vice President on April 30, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4). The awards include stock options for 125,000 shares with an exercise price of $0.93 and 20,000 RSUs, granted under the 2015 Inducement Award Plan. The stock options vest over four years, starting April 13, 2026, while the RSUs vest over three years...
05-07 01:15
SCYNEXIS Agrees With Poxel To Acquire PXL-770; $8M Upfront, Up To $188M Milestones
SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company focused on developing innovative new therapies to address severe rare diseases, today announced that it has entered into a definitive agreement with Poxel S.A.
03-31 18:43
